Ithaka Group LLC Incyte Corp Transaction History

Ithaka Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $5.07 Million - $6.99 Million	-83,269 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $219,278 - $266,587	-2,640 Reduced 3.07%	83,269 $6.94 Million
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $68,673 - $85,584	-734 Reduced 0.85%	85,909 $8.14 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $9.46 Million - $12 Million	86,643	86,643 $10.1 Million

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ithaka Group LLC, based on Form 13F filings with the SEC.

Stay updated on Ithaka Group LLC with notifications on news.